Expression of Membrane-Bound Mucins (MUC1 and MUC4) and Secreted Mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in Mucoepidermoid Carcinomas of Salivary Glands

Mucins are glycoproteins normally synthesized by a variety of secretory epithelial cells. The aim of this study was to investigate the expression of mucins (MUC1, MUC2, MUC4, MUC5AC, MUCB, MUC6, MUC7) in mucoepidermoid carcinomas, the most frequent malignant tumor of salivary glands. Forty mucoepidermoid carcinomas and twenty-two normal salivary glands were studied for these mucins by immunohistochemistry from formalin-fixed and paraffin-embedded material. Normal salivary glands frequently expressed MUC1 and MUC4, mainly in ductal cells; MUC5B and MUC7 stained mucous and serous acini respectively of submandibular and minor salivary glands; and MUC5AC and MUC2 were poorly detected in excretory ducts. All mucoepidermoid carcinomas expressed MUC1, and 38/40 tumors expressed MUC4. Both membrane-bound mucins stained membranes and cytoplasm of all cell types (epidermoid, intermediate, mucous, clear and columnar). MUC5AC and MUC5B stained glandular differentiated cells in most tumors (29/40 and 33/40 cases, respectively). MUC6 was positive in 13/40 tumors, and both MUC2 and MUC7 in only 2/40 tumors. The high expression of MUC1 was related to high histologic grades, high recurrence and metastasis rates and a shorter disease-free interval (P < 0.05). Conversely, MUC4 high expression was mainly related to low-grade tumors, lower recurrence rates and a longer disease-free interval (P < 0.05). In conclusion, mucoepidermoid carcinomas of salivary glands usually express MUC1, MUC4, MUC5AC and MUC5B; less frequently MUC6; and rarely MUC2 and MUC7. This mucin expression pattern can be useful for diagnostic purposes. Therefore, MUC1 expression is related to tumor progression and worse prognosis, whereas MUC4 expression is related to a better prognosis.

[1]  L. Thompson Mucoepidermoid Carcinoma , 2005, Ear, nose, & throat journal.

[2]  S. Batra,et al.  A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-β in pancreatic carcinogenesis , 2004, Oncogene.

[3]  G. Tonon,et al.  Multiple reciprocal translocations in salivary gland mucoepidermoid carcinomas. , 2004, Cancer genetics and cytogenetics.

[4]  K. Hamilton-Nelson,et al.  MUC4 and ERBB2 expression in major and minor salivary gland mucoepidermoid carcinoma , 2004, Head & neck.

[5]  J. Meza,et al.  Inhibition of MUC4 Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis , 2004, Cancer Research.

[6]  P. Fouret,et al.  Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation. , 2003, The American journal of pathology.

[7]  A. Prasad,et al.  Mucin-Rich Variant of Salivary Duct Carcinoma: A Clinicopathologic and Immunohistochemical Study of Four Cases , 2003, The American journal of surgical pathology.

[8]  A. Hand,et al.  Electron Microscopic Immunogold Localization of Salivary Mucins MG1 and MG2 in Human Submandibular and Sublingual Glands , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[9]  C. A. Carraway,et al.  Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27kip, but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways , 2002, Oncogene.

[10]  F. Sarkar,et al.  The Dichotomy in the Preinvasive Neoplasia to Invasive Carcinoma Sequence in the Pancreas: Differential Expression of MUC1 and MUC2 Supports the Existence of Two Separate Pathways of Carcinogenesis , 2002, Modern Pathology.

[11]  P. Toselli,et al.  Expression of Membrane-associated Mucins MUC1 and MUC4 in Major Human Salivary Glands , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  V. Eusebi,et al.  Low-grade mucoepidermoid carcinoma of salivary glands: characteristic immunohistochemical profile and evidence of striated duct differentiation , 2002, Virchows Archiv.

[13]  H. Friess,et al.  Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  S. Batra,et al.  Structural organization and classification of the human mucin genes. , 2001, Frontiers in bioscience : a journal and virtual library.

[15]  M. Urken,et al.  Mucoepidermoid Carcinoma: A Clinicopathologic Study of 80 Patients With Special Reference to Histological Grading , 2001, The American journal of surgical pathology.

[16]  J. Davies,et al.  Macromolecular organization of saliva: identification of 'insoluble' MUC5B assemblies and non-mucin proteins in the gel phase. , 2000, The Biochemical journal.

[17]  C. Reis,et al.  Role of fucosyltransferases in the association between apomucin and Lewis antigen expression in normal and malignant gastric epithelium , 2000, Gut.

[18]  K. Carraway,et al.  Potentiation of metastasis by cell surface sialomucin complex (rat MUC4), a multifunctional anti‐adhesive glycoprotein , 2000, International journal of cancer.

[19]  M. Copin,et al.  From normal respiratory mucosa to epidermoid carcinoma: Expression of human mucin genes , 2000, International journal of cancer.

[20]  M. Sobrinho-Simões,et al.  Immunohistochemical Study of the Expression of MUC6 Mucin and Co-expression of Other Secreted Mucins (MUC5AC and MUC2) in Human Gastric Carcinomas , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[21]  J. Yoo,et al.  H‐ras gene mutations in salivary gland mucoepidermoid carcinomas , 2000, Cancer.

[22]  P. V. van Diest,et al.  Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  D. Olive,et al.  Differential MUC 1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samples. , 1999, American journal of clinical pathology.

[24]  C. A. Carraway,et al.  An Intramembrane Modulator of the ErbB2 Receptor Tyrosine Kinase That Potentiates Neuregulin Signaling* , 1999, The Journal of Biological Chemistry.

[25]  M. Stöckle,et al.  Differential mucin MUC7 gene expression in invasive bladder carcinoma in contrast to uniform MUC1 and MUC2 gene expression in both normal urothelium and bladder carcinoma. , 1998, Cancer research.

[26]  R. Dodge,et al.  Mucin gene expression in ovarian cancers. , 1998, Cancer research.

[27]  D. Carter TNM Classification of Malignant Tumors , 1998 .

[28]  E. Veerman,et al.  MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage. , 1998, The Biochemical journal.

[29]  J. Robertson,et al.  MUC-1 mucin assays for monitoring therapy in metastatic breast cancer , 1998 .

[30]  F. Real,et al.  MUC6 expression in breast tissues and cultured cells: Abnormal expression in tumors and regulation by steroid hormones , 1998, International journal of cancer.

[31]  N. Kohno,et al.  Immunoreactive MUC1 Expression at the Deepest Invasive Portion Correlates with Prognosis of Colorectal Cancer , 1998, Oncology.

[32]  G. Ellis,et al.  Mucoepidermoid carcinoma of the major salivary glands , 1998, Cancer.

[33]  H. Stein,et al.  Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary , 1997, The Journal of pathology.

[34]  D. Swallow,et al.  Human mucin genes assigned to 11p15.5: identification and organization of a cluster of genes. , 1996, Genomics.

[35]  H. Clausen,et al.  Differential Expression of Human High-molecular-weight Salivary Mucin (MG1) and Low-molecular-weight Salivary Mucin (MG2) , 1996, Journal of dental research.

[36]  T. Hong,et al.  Mucin mRNA expression in lung adenocarcinoma cell lines and tissues. , 1996, Oncology.

[37]  I. Brockhausen,et al.  Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. , 1995, European journal of biochemistry.

[38]  M Garrido,et al.  MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. , 1995, Gastroenterology.

[39]  Walsh,et al.  Prognostic significance of MUC1 epithelial mucin expression in breast cancer. , 1995, Human pathology.

[40]  S. Gendler,et al.  Epithelial mucin genes. , 1995, Annual review of physiology.

[41]  M. Pike,et al.  Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. , 1994, Cancer research.

[42]  D. Ota,et al.  MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. , 1994, Gastroenterology.

[43]  M. Copin,et al.  Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[44]  R. Dahiya,et al.  Heterogeneity of mucin gene expression in normal and neoplastic tissues. , 1993, Cancer research.

[45]  S. Itzkowitz,et al.  Mucin gene expression in colonic tissues and cell lines. , 1992, Cancer research.

[46]  M. Ligtenberg,et al.  Cell membrane-associated mucins and their adhesion-modulating property. , 1992, Trends in biochemical sciences.

[47]  T. Duhig,et al.  Spatial and temporal expression of an epithelial mucin, Muc-1, during mouse development. , 1992, Development.

[48]  G. Ellis,et al.  Mucoepidermoid carcinoma of intraoral salivary glands evaluation and application of grading criteria in 143 cases , 1992, Cancer.

[49]  R. Spiro Salivary neoplasms: overview of a 35-year experience with 2,807 patients. , 1986, Head & neck surgery.

[50]  Gilmore Hr,et al.  Armed Forces Institute of Pathology. , 1968, Oral surgery, oral medicine, and oral pathology.